昨天有媒体报道说由于澳洲对辉瑞和莫德纳疫苗的需求，澳洲将不再生产阿斯利康疫苗。
CSL在简短声明中还说已经生产了2000万剂阿斯利康，预计其余的产量将于明年初完成。
https://www.reuters.com/resizer/Sxy_8c4iTGT-I29xeaTH3fAoLUU=/960×0/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/RFMEHDATXNKKFIZQMGIL5CYMCQ.jpg
https://www.reuters.com/business/healthcare-pharmaceuticals/australias-csl-reaffirms-commitment-making-astrazeneca-covid-vaccine-2021-10-13/
“唐人街”Fb每日分享澳大利亚精选新闻，让你随时随地知道澳洲最新 @玩乐、@移民、@生活资讯：https://www.fb.com/news.china.com.au/
【欢迎新闻爆料，洽谈合作！】微信订阅帐号：news-china-com-au